Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
Primary varicella zoster infection associated with fingolimod treatment.
Meningeal and Choroid Plexus Cells - Novel Drug Targets for CNS Disorders.
MicroRNA dysregulation in multiple sclerosis.
Alemtuzumab treatment of multiple sclerosis.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
Effects of Wii exercises on balance in people with multiple sclerosis.
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study.
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
Moral Distress: Recognition, Diagnosis, and Treatment.
Prenatal vitamin d deficiency induces an early and more severe experimental autoimmune encephalomyelitis in the second generation.
Postinfectious neurologic syndromes: A prospective cohort study.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Resilience and vulnerability in individuals with chronic pain and physical disability.
Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.
Pages
« first
‹ previous
…
281
282
283
284
285
286
287
288
289
…
next ›
last »